{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:15Z","timestamp":1772166255008,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) infection is currently the main cause of cervical cancer and precancerous lesions in female patients. By analyzing 6-year patient data from Shanghai Zhoupu Hospital in China, we retrospectively analyzed the epidemiological characteristics of women to determine the relationship between HPV genotype and cytological test results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From 2014 to 2019, 23,724 cases of cervical shedding were collected from Zhoupu Hospital in Shanghai, China. By comparing the results of HPV and ThinPrep cytology test (TCT), the HPV infection rate of patients was retrospectively analyzed. HPV genotyping using commercial kits can detect 21 HPV subtypes (15 high-risk and 6 low-risk). According to the definition of the Bethesda system, seven types of cervical cytology results were involved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>3816 among 23,724 women, nearly 16.08%, were infected with HPV. The top three highest HPV prevalence rates were high-risk type infection, including HPV52 (3.19%), 58 (2.47%) and 16 (2.34%). The number of single-type HPV infections (3480 (91.20%)) was much larger than the number of multi-type ones (336 (8.8%)). Single-type infections were mainly in women aged 50\u201360 (16.63%) and women under 30 (15.37%), while multi-type infections were more common in women over 60 (2.67%). By analyzing the long-term trends, between 2014 and 2019, HPV52, 58, and 16 subtypes changed significantly, and the HPV positive rate also changed significantly during this period. Among 4502 TCT positive women, 15 (4.04%), 125 (2.64%),159 (1.54%), 4202 (17.71%) and 1 (0.004%) had atypical glandular cells (AGC), high-grade squamous intraepithelial lesions (HSIL), low-grade squamous intraepithelial lesions (LSIL), atypical squamous cells (ASC)and cervical adenocarcinoma, respectively. The HPV infection rates were 66.08%, 63.99%, 115.20%, 119.50%, and 31.72% for NILM, AGCs, HSILs LSILs and ASCs, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HPV and TCT screening were very important steps in the secondary prevention of cervical cancer. Through the tracking and analysis of HPV and TCT results in this study, it can provide valuable information for Shanghai's HPV screening and prevention strategies, and provide references for clinical decision-making in the treatment of cervical cancer and precancerous lesions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-021-01518-y","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T07:02:51Z","timestamp":1615186971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Characteristics of human papillomavirus infection among women with cervical cytological abnormalities in the Zhoupu District, Shanghai City, China, 2014\u20132019"],"prefix":"10.1186","volume":"18","author":[{"given":"Ping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoling","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"issue":"2","key":"1518_CR1","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191\u2013203.","journal-title":"Lancet Glob Health"},{"key":"1518_CR2","doi-asserted-by":"crossref","unstructured":"Wei M, Zhou W, Bi Y, Wang H, Liu Y, Zhang ZJ. Rising mortality rate of cervical cancer in younger women in urban China. J Gen Internal Med, 2019; 34(2), 281-284","DOI":"10.1007\/s11606-018-4732-z"},{"key":"1518_CR3","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, He J. Cancer statistics in China15. CA, 2016; 66(2): 115-132."},{"key":"1518_CR4","first-page":"4614","volume":"11","author":"J Wu","year":"2018","unstructured":"Wu J, Li X, Liu X, Gao Z. Human papillomavirus genotype prevalence in the women of Shanghai, China and its association with the severity of cervical neoplasia. Int J Clin Exp Pathol. 2018;11:4614\u201321.","journal-title":"Int J Clin Exp Pathol"},{"key":"1518_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/jmv.24899","volume":"90","author":"C Zhang","year":"2018","unstructured":"Zhang C, Zhang C, Huang J, Wu Z, Mei X, Shi W. Prevalence and genotype distribution of human papillomavirus among females in the suburb of Shanghai China. J Med Virol. 2018;90:157\u201364.","journal-title":"J Med Virol"},{"key":"1518_CR6","doi-asserted-by":"publisher","first-page":"912","DOI":"10.12659\/MSM.905789","volume":"24","author":"C Zhang","year":"2018","unstructured":"Zhang C, Zhang C, Huang J, Shi W. The genotype of human papillomavirus and associated factors among high risk males in Shanghai, China: a molecular epidemiology study. Med Sci Monitor. 2018;24:912\u20138.","journal-title":"Med Sci Monitor"},{"key":"1518_CR7","doi-asserted-by":"crossref","unstructured":"Li X, Deng Y, Tang W, Sun Q, Chen Y, Yang C, Cao G. Urban-rural disparity in cancer incidence, mortality, and survivals in Shanghai, China, during 2002 and 2015. Front Oncol, 2018;8, 579","DOI":"10.3389\/fonc.2018.00579"},{"key":"1518_CR8","doi-asserted-by":"crossref","unstructured":"Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, Franceschi S. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer 2012, 131: 2929\u20132938.","DOI":"10.1002\/ijc.27571"},{"key":"1518_CR9","doi-asserted-by":"crossref","unstructured":"Giorgi Rossi P, Baldacchini F, Ronco G. The possible effects on socio-economic inequalities of introducing HPV testing as primary test in cervical cancer screening programs. Front Oncol 2014,4:20.","DOI":"10.3389\/fonc.2014.00020"},{"key":"1518_CR10","doi-asserted-by":"crossref","unstructured":"Li H, Li P, Huang L, Sun L, Ren H, Li P. Prevalence characteristics of cervical human papillomavirus (HPV) infection in the Zhoupu District, Shanghai City, China. Virol J 2020, 17:84.","DOI":"10.1186\/s12985-020-01352-8"},{"key":"1518_CR11","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, Ferrer E, Bosch F, de Sanjos\u00e9 S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789\u201399.","journal-title":"J Infect Dis"},{"key":"1518_CR12","doi-asserted-by":"crossref","unstructured":"Wang J, Tang D, Wang K, Wang J, Zhang Z, Chen Y, Ma C. HPV genotype prevalence and distribution during 2009\u20132018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Women's Health 2019, 19:90.","DOI":"10.1186\/s12905-019-0785-3"},{"key":"1518_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12905-019-0785-3","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang J, Tang D, Wang K, Wang J, Zhang Z, Chen Y, et al. HPV genotype prevalence and distribution during 2009\u20132018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Women\u2019s Health. 2019;19:90\u201390.","journal-title":"BMC Women's Health"},{"key":"1518_CR14","doi-asserted-by":"crossref","unstructured":"Ma L, Lei J, Ma L, Cong X, Wang N, Yang H, Cao Y. Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014\u20132018. BMC Infect Dis 2019, 19:670.","DOI":"10.1186\/s12879-019-4313-8"},{"key":"1518_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/jmv.24700","volume":"89","author":"L Wj","year":"2017","unstructured":"Wj L, Hx X, Zh C, Wd X, Yj W. Characteristics of carcinogenic human papillomavirus infection in Suzhou: Epidemiology, vaccine evaluation, and associated diseases. J Med Virol. 2017;89:895\u2013901.","journal-title":"J Med Virol"},{"key":"1518_CR16","doi-asserted-by":"crossref","unstructured":"Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, Kim JJ. An updated natural history model of cervical cancer: derivation of model parameters. Am J Epidemiol 2014, 180: 545\u2013555.","DOI":"10.1093\/aje\/kwu159"},{"key":"1518_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijid.2018.09.018","volume":"77","author":"B Tsedenbal","year":"2018","unstructured":"Tsedenbal B, Yoshida T, Enkhbat B, Gotov U, Sharkhuu E, Saio M, et al. Human papillomavirus genotyping among women with cervical abnormalities in Ulaanbaatar, Mongolia. Int J Infect Dis. 2018;77:8\u201313.","journal-title":"Int J Infect Dis"},{"key":"1518_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12985-020-01383-1","volume":"17","author":"Y Liu","year":"2020","unstructured":"Liu Y, Ang Q, Wu H, Xu J, Chen D, Zhao H, et al. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China\u2019s top 3 hospital, 2009\u20132019. Virol J. 2020;17:104.","journal-title":"Virol J"},{"key":"1518_CR19","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.3802\/jgo.2018.29.e14","volume":"29","author":"Y Ouh","year":"2018","unstructured":"Ouh Y, Min K, Cho H, Ki M, Oh J, Shin S, et al. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014\u20132016. J Gynecol Oncol. 2018;29:e14.","journal-title":"J Gynecol Oncol"},{"key":"1518_CR20","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.3802\/jgo.2017.28.e30","volume":"28","author":"X Zhao","year":"2017","unstructured":"Zhao X, Hu S, Zhang Q, Dong L, Feng R, Han R, et al. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population. J Gynecol Oncol. 2017;28:e30.","journal-title":"J Gynecol Oncol"},{"key":"1518_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/LGT.0000000000000487","volume":"23","author":"A Iacobone","year":"2019","unstructured":"Iacobone A, Bottari F, Radice D, Preti E, Franchi D, Vidal Urbinati A, et al. Distribution of high-risk human papillomavirus genotypes and multiple infections in preneoplastic and neoplastic cervical lesions of unvaccinated women: a cross-sectional study. J Lower Genital Tract Dis. 2019;23:259\u201364.","journal-title":"J Lower Genital Tract Dis"},{"key":"1518_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","volume":"374","author":"J Paavonen","year":"2009","unstructured":"Paavonen J, Naud P, Salmer\u00f3n J, Wheeler C, Chow S, Apter D, et al. Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet (Lond Engl). 2009;374:301\u201314.","journal-title":"Lancet (Lond Engl)"},{"key":"1518_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","volume":"372","author":"E Joura","year":"2015","unstructured":"Joura E, Giuliano A, Iversen O, Bouchard C, Mao C, Mehlsen J, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372:711\u201323.","journal-title":"N Engl J Med"},{"key":"1518_CR24","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S1473-3099(17)30468-1","volume":"17","author":"K Kavanagh","year":"2017","unstructured":"Kavanagh K, Pollock K, Cuschieri K, Palmer T, Cameron R, Watt C, et al. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. Lancet Infect Dis. 2017;17:1293\u2013302.","journal-title":"Lancet Infect Dis"},{"key":"1518_CR25","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1016\/j.vaccine.2018.02.003","volume":"36","author":"K Gallagher","year":"2018","unstructured":"Gallagher K, LaMontagne D, Watson-Jones D. Status of HPV vaccine introduction and barriers to country uptake. Vaccine. 2018;36:4761\u20137.","journal-title":"Vaccine"},{"key":"1518_CR26","doi-asserted-by":"crossref","unstructured":"Wei L, Su Y, Hu Y, Li R, Chen W, Pan Q, et al. Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18\u201345 years enrolled in a clinical trial. Clin Microbiol Infect 2020.","DOI":"10.1016\/j.cmi.2019.12.010"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-021-01518-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T07:09:33Z","timestamp":1615187373000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-021-01518-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1518"],"URL":"https:\/\/doi.org\/10.1186\/s12985-021-01518-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-51651\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-51651\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-51651\/v3","asserted-by":"object"}]},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Medical Ethics Review Board of Zhoupu Hospital in Shanghai City.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}